CDK4 and CDK6 drugs for Breast Cancer

3 tracked CDK4 and CDK6 drugs in the Breast Cancer race. The class explanation lives on the CDK4 and CDK6 page; the full indication pipeline across every mechanism is on the Breast Cancer page.

3 approved / phase 4

Head-to-head evidence: Abemaciclib vs Palbociclib · Abemaciclib vs Ribociclib · Palbociclib vs Ribociclib

The roster

← all CDK4 and CDK6 drugs